Wanbury Limited

NSE:WANBURY.NS

265.52 (INR) • At close September 19, 2024
Bedrijfsnaam Wanbury Limited
Symbool WANBURY.NS
Munteenheid INR
Prijs 265.52
Beurswaarde 8,694,585,160
Dividendpercentage 0%
52-weken bereik 60 - 270
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. K. Chandran
Website https://www.wanbury.com

An error occurred while fetching data.

Over Wanbury Limited

Wanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India. The company offers formulations for gynecology, orthopedics, heamatinics, anti-diabetic, nutraceuticals, gastro intestinal, stroke surgery, antibiotics, cough and cold solutions, anti-inflammatory, analgesics, and general practitioner purposes approximately under 70 brands. It also provides API products for anti-diabetic, anti-analgesic,

Vergelijkbare Aandelen

Brooks Laboratories Limited logo

Brooks Laboratories Limited

BROOKS.NS

150.48 INR

Sakar Healthcare Limited logo

Sakar Healthcare Limited

SAKAR.NS

328.45 INR

Kilitch Drugs (India) Limited logo

Kilitch Drugs (India) Limited

KILITCH.NS

369.3 INR

Krebs Biochemicals & Industries Limited logo

Krebs Biochemicals & Industries Limited

KREBSBIO.NS

90.59 INR

Par Drugs and Chemicals Limited logo

Par Drugs and Chemicals Limited

PAR.NS

234.05 INR

Lasa Supergenerics Limited logo

Lasa Supergenerics Limited

LASA.NS

27.12 INR

SMS Lifesciences India Limited logo

SMS Lifesciences India Limited

SMSLIFE.NS

1,488.65 INR

Mangalam Drugs & Organics Limited logo

Mangalam Drugs & Organics Limited

MANGALAM.NS

127.32 INR

Bal Pharma Limited logo

Bal Pharma Limited

BALPHARMA.NS

127.24 INR

Venus Remedies Limited logo

Venus Remedies Limited

VENUSREM.NS

343.5 INR

Financiële Gegevens

Cijfers zijn in miljoenen (INR)

Cijfers zijn in miljoenen (INR)